Skip to content

Phase 1 study to evaluate [18F]ACI-19626 as a potential PET radioligand for imaging TDP-43 inclusions in the brain of patients with suspected TDP-43 proteinopathies compared with healthy controls

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-513097-21-00
Acronym
ACI-19626-FTD-2301
Enrollment
45
Registered
2024-10-30
Start date
2024-11-20
Completion date
Unknown
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease, Familial and sporadic Amyotrophic lateral sclerosis, Familial and sporadic Frontotemporal dementia, Suspected limbic predominant age-related TDP-43 Encephalopathy (LATE)

Interventions

None listed

Sponsors

AC Immune SA
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026